Plontke, Stefan K.
Rahne, Torsten
Curthoys, Ian S.
Håkansson, Bo
Fröhlich, Laura
Article History
Accepted: 1 February 2022
First Online: 1 June 2022
Declarations
:
: S. K. Plontke, T. Rahne, I. S. Curthoys, B. Håkansson and L. Fröhlich declare that they have no conflict of interest related to the submitted work. Outside the submitted work the following financial activities during the last three years are declared for all authors (initials): Personal consultancies: AudioCure Pharma GmbH, Berlin, Germany (S. K. Plontke). Institutional research collaborations and projects: MEDEL, Austria (S. K. Plontke, L. Fröhlich, T. Rahne); Cochlear, Australia (S. K. Plontke, T. Rahne); Oticon Medical, Denmark (S. K. Plontke, T. Rahne, B. Håkansson); Schwabe Arzneimittel, Germany (S. K. Plontke). Travel support for lectures: MED-EL, Austria (S. K. Plontke, L. Fröhlich, T. Rahne). Honoraria for lectures or session moderations: Infectopharm, Germany; Merck Serono, Darmstadt, Germany; Schwabe Arzneimittel, Germany (S. K. Plontke).
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: The supplement containing this article is not sponsored by industry.